PT  - JOURNAL ARTICLE
AU  - Kwong, Alex S. F.
AU  - Northstone, Kate
AU  - Pearson, Rebecca M.
AU  - McIntosh, Andrew M.
AU  - Timpson, Nicholas J.
TI  - Tracking population mental health before and across stages of the COVID-19 pandemic in young adults
AID  - 10.1101/2022.03.24.22272899
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.24.22272899
4099  - http://medrxiv.org/content/early/2022/03/25/2022.03.24.22272899.short
4100  - http://medrxiv.org/content/early/2022/03/25/2022.03.24.22272899.full
AB  - The SARS-CoV-2 (COVID-19) pandemic has been associated with worsening mental health. Longitudinal studies have monitored changes in mental health from pre-pandemic levels, identifying critical points for mental health as COVID-19 restrictions evolve. Here we highlight changes in depression and anxiety in the UK from pre-pandemic across four pandemic occasions: April and June 2020, January, and July 2021 – corresponding to changes in COVID-19 restrictions. Data were from >5,000 27–29-year-olds from the Avon Longitudinal Study of Parents and Children (ALSPAC). We found that anxiety almost doubled throughout the pandemic compared to pre-pandemic levels and remained high until July 2021 when COVID-19 restrictions were fully lifted. Depression was lower than pre-pandemic levels in April 2020 but increased as the pandemic evolved until July 2021. Women, those with existing mental/physical health conditions and those with economic hardship were most at risk of sustained poorer mental health across the pandemic. Our results highlight the importance of longitudinal studies for tracking mental health during the COVID-19 pandemic and across virus suppression policy changes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe UK Medical Research Council and Wellcome (Grant Ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grant funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). This work was supported by the Elizabeth Blackwell Institute, University of Bristol, Wellcome Trust Institutional Strategic Support Fund and Rosetrees Trust (Grant Refs: 204813/Z/16/Z; R105121). ASFK, RMP and NJT work in, or are affiliated to, the MRC Integrative Epidemiology Unit which is funded by the University of Bristol and UK Medical Research Council (MC_UU_00011/3 and MC_UU_00011/6). European Research Council under the European Unions Seventh Framework Programme, and grants 758813, MHINT and 669545 from the European Research Council Grant Agreements. AMM is supported by the Wellcome Trust (220875/Z/20/Z). This work was also supported by Wellcome through the Wellcome Longitudinal Population Studies COVID-19 Secretariat and Steering Group (UK LPS COVID co-ordination, Grant Ref: 221574). NJT is a Wellcome Trust Investigator (202802/Z/16/Z), is the PI of the Avon Longitudinal Study of Parents and Children (MRC * WT 217065/Z/19/Z), is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215-2001), the MRC Integrative Epidemiology Unit (MC_UU_00011/1) and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A29019).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the Avon Longitudinal Study of Parents And Children Ethics and Law Committee and the Local Research Ethics Committees.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe ALSPAC study website contains details of all data available through a fully searchable data dictionary (http://www.bristol.ac.uk/alspac/researchers/our-data/). http://www.bristol.ac.uk/alspac/researchers/our-data